Tumour cells with this signature fail to execute TGF-β/SMAD-mediated growth arrest; rather, they undergo EMT in which cells lose cell polarity and cell–cell contacts, become more motile, and acquire fibroblast-like properties. This evidence concerns the gene TGFB1 and neoplasm.